Share-Based Compensation (Tables)

6 Months Ended

Jun. 30, 2026

Share-Based Payment Arrangement [Abstract]

Schedule of Share-Based Compensation Expense

The following table presents the total share-based

compensation expense resulting from equity awards and the

15.0% discount for the ESPP for the three and six months

ended June 30, 2026 and 2025, which is primarily included in

compensation and benefits expense in the Condensed

Consolidated Statements of Income:

	Three Months Ended June 30,		Six Months Ended June 30,
	2026	2025	2026	2025
	(in millions)
Share-based compensation expense before income taxes	$50	$46	$87	$81

Schedule of Restricted Stock Activity

The following table summarizes our restricted stock activity

for the six months ended June 30, 2026:

	Restricted Stock
	Number of Awards	Weighted-Average Grant Date Fair Value
Unvested at December 31, 2025	3,920,464	$64.06
Granted	1,410,453	82.65
Vested	(1,277,881)	59.02
Forfeited	(127,935)	69.56
Unvested at June 30, 2026	3,925,101	$72.21

Schedule of PSU Activity

The following table summarizes our PSU activity for the six

months ended June 30, 2026:

	PSUs
	Number of Awards	Weighted- Average Grant Date Fair Value
Unvested at December 31, 2025	2,378,130	$74.91
Granted	1,021,588	92.19
Vested	(778,716)	52.72
Forfeited	(9,890)	87.83
Unvested at June 30, 2026	2,611,112	$87.15

Schedule of Stock Option Activity

A summary of our outstanding stock options at June 30, 2026

is as follows:

	Number of Stock Options	Weighted- Average Exercise Price	Weighted- Average Remaining Contractual Term (in years)	Aggregate Intrinsic Value (in millions)
Outstanding at December 31, 2025	1,420,323	$41.79
Exercised	(806,451)	22.23
Outstanding at   June 30, 2026	613,872	$67.49	5.5	$7

Schedule of Valuation Assumptions

The following weighted-average assumptions were used to

determine the weighted-average fair values of the outstanding

PSU awards granted under the three-year PSU program

during the six months ended June 30, 2026 and 2025:

Year of grant date	2026	2025
Weighted-average risk-free interest rate	3.80%	3.82%
Expected volatility	22.57%	23.27%
Weighted-average grant date share price	$85.24	$76.04
Weighted-average fair value at grant date	$100.20	$92.43